Platelet/ lymphocyte ratio for prediction of no reflow phenomenon in ST elevation myocardial infarction managed with primary percutanous coronary intervention
Author(s) -
Hala Mahfouz Badran,
Ahmed Fatah,
Ghada Soltan
Publication year - 2020
Publication title -
journal of clinical and translational research
Language(s) - English
Resource type - Journals
eISSN - 2424-810X
pISSN - 2382-6533
DOI - 10.18053/jctres.06.202001.004
Subject(s) - no reflow phenomenon , medicine , cardiology , myocardial infarction , percutaneous coronary intervention , thrombolysis , ejection fraction , neutrophil to lymphocyte ratio , heart failure , lymphocyte
Coronary no-reflow phenomenon in ST-segment elevation myocardial infarction (STEMI) is associated with a poor clinical outcome. Although its pathophysiology is not fully understood, a deregulated systemic inflammatory response plays an important role. We aimed to explore the relationship between platelet\lymphocyte ratio (PLR) and no-reflow in patients with acute STEMI who were treated with a primary percutaneous coronary intervention (PPCI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom